Cargando…
Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy
Background: Nebulised medical aerosols are designed to deliver drugs to the lungs to aid in the treatment of respiratory diseases. However, an unintended consequence is the potential for fugitive emissions during patient treatment, which may pose a risk factor in both clinical and homecare settings....
Autores principales: | McGrath, James A., O’Toole, Ciarraí, Bennett, Gavin, Joyce, Mary, Byrne, Miriam A., MacLoughlin, Ronan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630289/ https://www.ncbi.nlm.nih.gov/pubmed/31159408 http://dx.doi.org/10.3390/pharmaceutics11060254 |
Ejemplares similares
-
Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
por: McGrath, James A., et al.
Publicado: (2019) -
An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021) -
In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
por: Bennett, Gavin, et al.
Publicado: (2019) -
In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance
por: Bennett, Gavin, et al.
Publicado: (2018) -
In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment
por: McGrath, James A., et al.
Publicado: (2022)